Newsletter | February 4, 2026

02.04.26 -- Money In The Bank: Why 2025's Setbacks Were The Foundation RNA Needed

SPONSOR

Join leading mRNA experts at the 5th Annual mRNA Analytical Development & Quality Control Summit - the only dedicated forum tackling analytical rigor, QC strategies, evolving regulatory expectations, and innovation from early- to late-phase therapeutics. With world-class speakers, case studies, and networking, this is your chance to stay ahead. Download the full agenda now to explore sessions shaping the future of mRNA analytics! Discount code: AR6355810

FEATURED EDITORIAL

Money In The Bank: Why 2025's Setbacks Were The Foundation RNA Needed

I saw 2025 as a foundational year for learning more about the function of our products. However, there were two developments in particular that, to me, encapsulated the trials, tribulations, and ultimately the success of an industry trying to answer one of its biggest questions: “Why RNA?”  

Assessing The Quality & Maturity Of The Next-Gen Oligo Supply Chain

As our molecules grow more complicated, so, too, does the supply chain. Advancing RNA Live speakers Khaled Yamout & Satya Kuchimanchi talk through how this growth challenges our understanding of raw material quality and how sponsors can better assess their suppliers.

Why RNA Tech Transfer Is So Hard — And How the Field Can Fix It

A closer look at why RNA tech transfer remains one of the field’s toughest bottlenecks — and the practical steps developers and CDMOs can take to finally streamline the path to GMP.

INDUSTRY INSIGHTS

The Current And Future Value Of mRNA Vaccines And Therapeutics

Discover how decades of research have propelled mRNA technology to the forefront of therapeutic development and learn how our expertise is advancing mRNA drug development.

The Evolution Of Nucleotide Production

From harsh chemicals to gentle enzymes: Explore the groundbreaking shift in nucleotide synthesis, making drug manufacturing cleaner, greener, and more efficient.

Five Practical Considerations To Move From Concept To Clinic

Learn more about five key factors for advancing targeted in vivo LNP programs, from formulation and targeting strategies to bioanalytical readiness and scalability.

Twist Of Two: 2D-LC For Oligos

Gain insight into how coupling orthogonal mechanisms reveals hidden impurities and creates a more robust strategy for characterizing complex oligonucleotide samples.

Supporting Complex Manufacture Of Liquid And Lyophilized Drug Products

Aseptic fill and finish operations gain efficiency and precision with modular isolator technology, inline weight checks, and lyophilization, which are ideal for mRNA-LNPs and other sensitive modalities.

SOLUTIONS

RNA Therapies

Our Spokane Foreign Trade Zone (FTZ)

A CRO Accelerating Bioanalysis